Buti M, Wong J, Casado MA, Esteban R
Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients
J Hepatol. 2006;44(Suppl 1):S60-S64
Buti M, Casado MA, Fosbrook L, Esteban R
Financial impact of two different ways of evaluating early virological response to peginterferon alfa-2b plus ribavirin therapy in genotype 1 naïve patients with chronic hepatitis C
Pharmacoeconomics. 2005;23:1043-55
Buti M, Sanmiguel R, Brosa M, Cabasés JM, Medina, M, Casado MA, Fosbrook L, Esteban R
Estimating the impact of hepatitis C virus therapy on the future liver-related morbidity, mortality and costs related to chronic hepatitis C
J Hepatol. 2005;42:639-45
Maymó J, Pérez C, Poveda JL, Fosbrook L, Casado MA, Pocoví A, Merino P